Literature DB >> 2503520

Immunohistochemical and biochemical characterization of antisera raised to human tumor nucleoli.

R S Greenfield1, M O Lamon, L J Olech, J A Grattan.   

Abstract

Antinucleolar antisera were raised in rabbits, goats and sheep to nucleoli isolated from three human tumor cell lines. The antisera were shown to cross-react by immunofluorescence with human tumor cell lines originating from different organs and with frozen sections from a wide variety of human malignant and non-malignant tissues. Tumor versus normal tissue discrimination by several antisera was significantly improved by treatment of frozen tissues with a buffered glutaraldehyde/Triton X-100 solution prior to immunofluorescent staining. The molecular specificity of these antisera was determined by immunostaining electrotransfer nitrocellulose strips following SDS-PAGE of nucleolar preparations and nuclear extracts. Although different immunostaining patterns were obtained for individual antinucleolar antisera, nucleolar proteins of molecular weight 120, 100, 94, 68, 54, 38, 33, and 32 kDa were the most often recognized by antisera raised in the three different species. G187 antiserum strongly reacted with 100, 94, and 38 kDa proteins from freshly obtained leukemic specimens. The Immunoreactivity of the 100, 94, and 38 kDa proteins was unaffected by glutaraldehyde/Triton X-100 treatment when immunostained with antisera that demonstrated the greatest tumor specificity on sections treated with glutaraldehyde/Triton X-100. These three nucleolar proteins may be more highly associated with nucleoli of malignant cells than with nucleoli of normal cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503520     DOI: 10.1007/bf00400962

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  19 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  DNA aneuploidy in Hodgkin's disease. A multiparameter flow-cytometric analysis with cytologic correlation.

Authors:  J Anastasi; K D Bauer; D Variakojis
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

4.  Purification and partial characterization of nucleolar antigen-1 of the Novikoff hepatoma.

Authors:  F Marashi; F M Davis; R K Busch; H E Savage; H Busch
Journal:  Cancer Res       Date:  1979-01       Impact factor: 12.701

5.  An enzyme immunoassay for the detection of human tumor nucleolar antigens.

Authors:  D E Kelsey; R K Busch; H Busch
Journal:  Cancer Lett       Date:  1981-05       Impact factor: 8.679

6.  Nucleolar antigen found in several human tumors but not in the nontumor tissues studied.

Authors:  F M Davis; F Gyorkey; R K Busch; H Busch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  Human malignancy-associated nucleolar antigen (HuMANA) and zinc in human prostatic tissues.

Authors:  F Gyorkey
Journal:  Prog Clin Biol Res       Date:  1981

8.  Identification and partial characterization of a nucleolar antigen with a molecular weight of 145,000 found in a broad range of human cancers.

Authors:  J W Freeman; D K McRorie; R K Busch; F Gyorkey; P Gyorkey; B E Ross; W H Spohn; H Busch
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

9.  Results of a preliminary "blind" study on the presence of the human tumor nucleolar antigen in breast carcinomas, benign breast tumors, and normal breast tissues.

Authors:  H Busch; R K Busch; P K Chan; W Isenberg; R Weigand; J Russo; P Furmanski
Journal:  Clin Immunol Immunopathol       Date:  1981-02

10.  Isolation and partial characterization of a nuclear antigen (68/6.3) from the Namalwa cell line (a Burkitt lymphoma).

Authors:  P K Chan; R L Frakes; R K Busch; H Busch
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.